| Date |
Report No. |
Title |
| Date Sept. 30, 1992 |
Report No. HRD-92-110 |
Title
c
lJnited States General Accounting Office GAO
September 1992 Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce; House of Representatives PRESCRIPTION DRUGS Companies Q-pieally Charge More in the United States Than in Canada
,- aESTRICTED--Not to be released outside the General Accounting Offke unless specifically approved by the Office of Congres... |
| Date Aug. 31, 1992 |
Report No. RCED-92-231 |
Title
All~llst. awz CANCER TREATMENT Actions Taken to More Fully Utilize the ESark of Pacific Yews on Federal Land RESTI&ICTEIX-Not to be ?eleas&l~outside ‘the General Accounting Office unless specifically approved by the Offke of Congressional Relations., ” ..-- -.. ._-. I.-...~..I*.. --.-..I..--...-.----_ ..” . . -_-_-_--I -. i m GAO United Statee General Accounting OffIce Washington, D.C. 20648... |
| Date Aug. 5, 1992 |
Report No. RCED-92-209 |
Title
FOOD SAFETY AND QUALITY FDA Strategy Needed to Address Animal Drug Residues in Milk
,-. II lllllM Ill
147221 .._ b . .__ .__. --..ll.-- ._--. .._. I” .-I_--. ----~.- (;Ao,IRCEI)-92-209 GAO United States General Accounting Office Washington, D.C. 20548 Resources, Community, and Economic Development Division B-246269 August 5,1992 The Honorable Ted Weiss Chairman, Human Resourcesand Intergovernmen... |
| Date Aug. 5, 1992 |
Report No. T-RCED-92-89 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Wednesday August 5, 1992 Testimony
Before the Human Resources and Intergovernmental Relations Subcommittee Committee on Government Operations House of Representatives FOOD SAFETY AND QUALITY FDA Strategy Needed Address Animal Drun Residues in Milk
Statement of John W. Harman, Director, Food and Agricultu... |
| Date April 28, 1992 |
Report No. T-PEMD-92-8 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at IO:00 am., EDT Tuesday, April 28, 1992 Testimony
Before the Subcommittee on Regulation, Business Opportunities and Energy Committee on Small Business House of Representatives OVER THE COUNTER DRUGS Gaps and Potential Vulnerabilities in the Regulatory System
Statement of Kwai-Cheung Chan Director of Program Evaluation i... |
| Date April 8, 1992 |
Report No. T-PEMD-92-5 |
Title
Uniied States General Accounting Office GAO
For releaseon Delivery Expected at IO:00 a.m., EDT Wednesday, April 8, 1992 Testimony
Before the Subcommitteeon Human Resources and Intergovernmental Relations Committee on Government Operations House of Representatives NONPRESCRIPTION DRUGS Over the Counter and Underemphasized
Statementof Kwai-Cheung Chan Director of Program EvaIuation in Physical Syste... |
| Date April 7, 1992 |
Report No. HRD-92-85 |
Title
GAO United States General Accounting OflIce Washington, D.C. 20648 Human Resources Division B-248171 April 7,1992 The Honorable William J. Hughes Chairman, Subcommittee on Intellectual Property and Judicial Administration Committee on the Judiciary House of Representatives The Honorable Dennis DeConcini Chairman, Subcommittee on Patents, Copyrights, and Trademarks Committee on the Judiciary Unite... |
| Date April 7, 1992 |
Report No. HRD-92-86 |
Title
GAO
FDA PREmmT.. .. .__.. _ APPROVAL Process of Approving Ol.estra as a Food Additive #I lllllll1lllll
146387 __ _ ..-_--. _-.-.” GAO United States General Accounting OfTIce Washington, D.C. 20648 Human Resources Division B-247488 April 7,1992 The Honorable William J. Hughes Chairman, Subcommittee on Intellectual Property and Judicial Administration Committee on the Judiciary House of Representa... |
| Date March 4, 1992 |
Report No. T-RCED-92-36 |
Title
United StatesGeneral Accounting Of&e Testimony
Before the Sub. on Fisheriesand Wildlife Conservationand the Environment, Corn. on Merchant Marine and Fisheries;the Sub. on National Parks and Public Lands, Corn. on Interior and Insular Affairs; and the Sub. on Forests,Family Farmsand Energy, Corn. on Agriculture, House of Representatives
For Release on Delivery Expected at IO:00 a.m., EST Wednesday... |
| Date Jan. 17, 1992 |
Report No. RCED-92-63 |
Title
.- .._ __.... .__. ._ .._._.... - .,......._. . -._ .- t,44 .-.-I.--.-.-.-~-----~.~ Of’f’iw ^... -........... Sl.;tIJvs (;c~~rc~r;rl Acwbunling --.___ ~I. tIlli..“l-._-.-l-“l.-- -.“-.- --_.-I_-- FOOD SAFETY AND QUALITY FDA Needs Stronger Controls Over the Approval Process for New Animal Drugs GAO unitedstatee General Accounting Offlce
Washington, D.C. 20648 Resources, Community, and Econ... |
| Date Jan. 14, 1992 |
Report No. PEMD-92-5 |
Title
DRUG ABUSE RESEARCH Federal Funding and Future Needs
.., 1111111 Ill1 llll
146460 RESTRICTED--Not to be released outside the General Accounting Offke unless specifically approved by the Office of Congressional Relations. Program Evaluation and Methodology Division B-246466 January 14,1992 The Honorable John Conyers, Jr. Chairman, Committee on Government Operations House of Representatives Dear Mr.... |
| Date Jan. 10, 1992 |
Report No. PEMD-92-9 |
Title
rlltllm-y 199% NONPRESCRIPTION DRUGS Over the Counter and Underemphasized GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-246187 January lo,1992 The Honorable Ron Wyden Chairman, Subcommittee on Regulation, Business Opportunities, and Energy Committee on Small Business House of Representatives Dear Mr. Chairman: In your letter of Feb... |
| Date Sept. 27, 1991 |
Report No. PEMD-91-14 |
Title
Reimbursement Policies Constrain Physicians in Their Choice of Cancer Therapies GAO,‘ I~:MI)-9 I’ 1- I4 Program Evaluation and Methodology Division B-24286 1 September 27,lQQl The Honorable Edward M. Kennedy Chairman, Committee on Labor and Human Resources United States Senate Dear Mr. Chairman: At your request, we have studied the prevalence of off-label use of anticancer drugs; how that use ... |
| Date Sept. 25, 1991 |
Report No. T-PEMD-91-14 |
Title
7- 01 m United States General Accounting Office/ f# 7 j %’ Testimony I 144955
-~~ .~~ t II b For Release on Delivery Expected at 2:30 p.m. EDT Wednesday September 25, 1991 Drug Abuse Research: Federal Funding and Future Needs Statement of Eleanor Chelimsky Assistant Comptroller General Program Evaluation and Methodology Division Before the Subcommittee on Legislation and National Committee on Go... |
| Date Feb. 25, 1991 |
Report No. PEMD-91-12BR |
Title
11 1;
Ji Jo t -- __...._ -----. ^.-- ______ -..._.__.__- _........ - United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-242851 February 25,199l The Honorable Edward M. Kennedy Chairman, Committee on Labor and Human Resources United States Senate Dear Mr. Chairman: In September 1989, you asked us to conduct a study on reimbursement denials ... |
| Date Jan. 30, 1991 |
Report No. HRD-91-55FS |
Title
DRUG ABUSE The Crack Cocaine Epidemic: Health Consequences and Treatment 1’ a:, I 1* _ .__.._..._.._ -__--..-..-.---_-.----..-.---.- .._ --_-..--_-_--l_-._---------~-J ___--. GAO United States General Accounting Office Washington, D.C. 20648 Human Resources Division B-242736 January 30,199l The Honorable Charles Range1 Chairman, Select Committee on Narcotics Abuse and Control House of Representa... |
| Date April 26, 1990 |
Report No. PEMD-90-15 |
Title
P United States General Accounting Office GAO
April 1990 Report to the Chairman, Subcommittee . on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives FDA DRUG REVIEW Postapproval Risks
1976-85 Not to be released outside the BESTRICTEDGeneral Accounting Office def38 SPeCme GAO/PEMD-90-15 United States General Accounting Office Washington, D... |
| Date Sept. 15, 1989 |
Report No. HRD-89-142 |
Title
U&ted States General Accounting Office “GAO
September 1989 Report to Congressional Requesters - FDA RESOURCES Comprehensive Assessment of Staffing, Facilities, and Equipment Needed g GAO/HRD-89-142 .. \! 2 ,’ ,1 Human Resources Division B-23.57 13 September 15, 1989 The Honorable Edward M. Kennedy, Chairman The Honorable Orrin G. Hatch, Ranking Minority Member Committee and Labor and Human Res... |
| Date June 13, 1989 |
Report No. IMTEC-89-58 |
Title
United States General Accounting Office GAO
June 1989 I Report to Congressional Requesters ADPPLANNING
FDA’s Plans to Improve Processing of Medical Device and Drug Applications GAO/IMTEC-89-58 -- GAO General Accounting Office Waahington, D.C. 20648 Information Management and Technology Division united states
B-223076 June 13,1989 The Honorable Quentin N. Burdick Chairman, Subcommittee on Agricul... |
| Date May 24, 1989 |
Report No. PEMD-89-18 |
Title
Report to the Chairman, Special Committee on Aging, U.S. Senate May 1989 PRESCRIPTION DRUGS Infomation on Selected Drug Utilization Review Systems GAO/PEMD-89-18 GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-235483 May 24,1989 The Honorable David Pryor Chairman, Special Committee on Aging United States Senate Dear Mr. Chairman: You... |
| Date Feb. 28, 1989 |
Report No. PEMD-89-9 |
Title
GAO
February 1989 Report to the Chairman, Subcommittee on-* Health and the Environment, Committee on Energy and Commerce, House of Representatives - BREAST C..NCER Patients’ Survival GAO/PEMD-89-9 About Our New Cover... GAO'S efforts The new color of our report covers represents the latest step in to improve the presentation of our reports. Program Evaluation and Methodology Division B-226468 Fe... |
| Date Sept. 5, 1986 |
Report No. IMTEC-86-32 |
Title
. , 1 * ? United States General Accounting Office “GAO
September 1986 Report to the Chairman, Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations House of Representatives I DRUG REGULATION, FDA’s Computer Systems Need ,fb Be I Better Managed nl~llllln~~
131277 p#STPUIC~D-- Not, $0 be rdsnseb
Ofikk? Of o-3
icxiad~m. tho CfaXd Accounting approval b... |
| Date Sept. 26, 1983 |
Report No. HRD-83-52 |
Title
Report To The Honorable Paula liawkins United tates Senate RELEASED OF THE UNITEDSTATES
Improvements Needed In Clinical Testing Of Anticancer Drugs Despite improvements Administration (FDA) (NCI) have carried out patients during clinical improvements should in the way the Food and Drug and the National Cancer Institute their responsibilities of protecting testing of anticancer drugs, further be ma... |
| Date June 23, 1983 |
Report No. 121728 |
Title
UNITED STATES GENERALACCOUNTING OFFICE WASHINGTON,D.C. 20548 FOR RELEASE ON DELIVERY Expected at 9:30 A.M. EDT June 23, 1983 STATEMENTOF EDWARD DENSMORE,DEPUTY DIRECTOR, HUMANRESOURCES A. DIVISION BEFORETHE SENATE COMMITTEEON LABOR AND HUMANRESOURCES ON THE CLINICAL TESTING OF ANTICANCERDRUGS Madam Chairman, our review
1 we are pleased testing to be here today of anticancer to discuss of the clini... |
| Date April 26, 1982 |
Report No. HRD-82-41 |
Title
I. 1 L ,jej+$-f/ //g/q6 ’ BY THECOMPTROLLER GENERAL Report To The Congress
OF THEUNITEDSTATES
FDA’s Approach To Reviewing Over-The-Counter Drugs Is Reasonable, But Progress Is Slow
F’ederal law requires the Food and Drug Administration to ensure that drugs sold csver the counter are safe and effective. FDA has designed a reasonable approach to regulating this large market, where retail sales... |
| Date Nov. 23, 1981 |
Report No. HRD-82-16 |
Title
Comptroller General
CiF THE UNITEDSTATES Speeding Up The Drug Review Ffrocess:Results Encouraging -E&t Progress Slow G ’0 is recommending actions that the Secreta of Health and Human Services could take to 4Yurther reduce drug review time. 117126 tj RD.8246 NOVEMBEdr 23,1981 Raquast for copies of GAO reports should be sent to: U.S. General Accounting Office Document Handling and Information Serv... |
| Date July 17, 1981 |
Report No. HRD-81-125 |
Title
UNITED STATES GENERAL ACCOUNTINGOFFICE
WASHINGTON, D.C. 20548 HUMAN RESOURCES DIVISION B-202161 The Honorable Henry A. Waxman Subcommittee on Health Chairman, and the Environment Committee on Energy and Commerce House of Representatives Dear Mr. 115882 Chairman: -P----" "1) (HRD-81-125) Subject: Federal Drug Development Programs L J This is in response to your request that we develop information o... |
| Date June 6, 1980 |
Report No. HRD-80-55 |
Title
Comptroller General FDA Bureau Of Biologics’ Regulation Activities
The Food and Drug Administration’s Bureau of Biologics regulates certain drugs, including those used to diagnose and treat allergies and to vaccinate people against a number of communicable diseases. This report answers questions by several Senators concerning --allergenic product regulation; safety, --biological tests to ensur... |
| Date Feb. 28, 1980 |
Report No. HRD-80-53 |
Title
The Honorable Edward Fl. Kennedy Chairman, Subcommittee on Heal@ 81,,~: :;I"'. " JS and Scientific Research Committee on Labor and Human Resources Vnited States Senate Dear Xr, Chairman:
_ I i pI '8, - ,1):" Subject: Review of '%cquisition (HRD-80-53) Cancer Institute's the Xational and Screening of Plant Extracts -~'1 letter asked us to review Your January 18, 1979, selected research management a... |
| Date Sept. 24, 1979 |
Report No. HRD-79-85A |
Title
STUDY THESTAFFOFTHE BY US, /io%37 l General Accounting Office
“A Review Of Research Literature And Federal Involvement Relating To Selected Obstetric Practices
Research literature does not resolve the controversy over U S obstetric practices The literature IS generally mconcluslve about the benefits versus risks for five selected obstetric practices elective induction of labor, medication to rel... |
| Date Sept. 24, 1979 |
Report No. HRD-79-85 |
Title
r- . BY THECOMPTROLLERGENERAL Report ToThe Congress
OF THEUNITEDSTATES Evaluating Benefits And RisksOf Obstetric Practices--More Coordinated Federal And Private Efforts Needed
The Federal Government, through the Department of Health, Education, and Welfare, has a number of responslbMles relating to U S obstetric practices, including --ensuring the safety of drugs and medical --funding fessional ti... |
| Date June 19, 1979 |
Report No. 109679 |
Title
DNITEL STATES GENERAL ACCOUNTING I3.C. 20546 OFFICE WASHINGTON, FOR RELEASE GPj DELIVERY EXFECTEC AT lG:OO A.M. EDT JUNE 19, 1'379 GREGORY J. STATEMENT OF GIRECTOR, HUMAN RESOURCES CIVISION BEFORE THE COMMITTEE ON SCIENCE ANG TECHNOLOGY SUECOMMITTEE ON SCIENCE, RESEARCH ANC TECHNOLOGY OPi THE: FOOLj ANL; I;RUG ADMINISTRATION'S CRUG APFROVAL, YROCkSS AHART, J 109679 Mr.
Fleased our review Chairmen ... |
| Date April 4, 1978 |
Report No. 093973 |
Title
|
| Date June 27, 1977 |
Report No. HRD-77-115 |
Title
|
| Date July 15, 1976 |
Report No. HRD-76-96 |
Title
Food and Drug /M-ministration Department of Health, Education, and Welfare The Food and Drug Administration has neither adequately monitored new drug tests nor adequately enforced compliance with testing requirements. Consequently, it lacks assurance (1) that the thousands of human subjects used in such tests annually are protected from unnecessary hazards of new drugs or (2) that the test data us... |
